Clinical Trial Update: The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating insulin detemir for blood glucose control in Taiwanese patients with Type 2 diabetes not controlled on oral antidiabetic drugs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin detemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED